Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1947 2
1948 1
1949 5
1950 15
1951 10
1952 6
1953 4
1954 9
1955 3
1956 7
1957 8
1958 15
1959 5
1960 11
1961 5
1962 5
1963 11
1965 11
1966 7
1967 7
1968 3
1969 5
1970 6
1971 2
1972 2
1973 2
1974 2
1976 2
1977 6
1978 5
1979 4
1980 5
1981 8
1982 5
1983 12
1984 11
1985 9
1986 7
1987 10
1988 18
1989 9
1990 12
1991 18
1992 16
1993 21
1994 21
1995 30
1996 29
1997 53
1998 47
1999 51
2000 38
2001 40
2002 52
2003 44
2004 46
2005 57
2006 53
2007 69
2008 66
2009 62
2010 91
2011 83
2012 140
2013 129
2014 99
2015 126
2016 125
2017 110
2018 134
2019 124
2020 184
2021 165
2022 205
2023 187
2024 160

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,835 results

Results by year

Filters applied: . Clear all
Page 1
PARP Inhibitors for Breast Cancer Treatment: A Review.
Morganti S, Marra A, De Angelis C, Toss A, Licata L, Giugliano F, Taurelli Salimbeni B, Berton Giachetti PPM, Esposito A, Giordano A, Bianchini G, Garber JE, Curigliano G, Lynce F, Criscitiello C. Morganti S, et al. Among authors: giordano a. JAMA Oncol. 2024 May 1;10(5):658-670. doi: 10.1001/jamaoncol.2023.7322. JAMA Oncol. 2024. PMID: 38512229 Review.
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation.
Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, Erba AP, Ferrari C, Mainolfi CG, Palucci A, Prandini N, Baldari S, Bartoli F, Bartolomei M, D'Antonio A, Dondi F, Gandolfo P, Giordano A, Laudicella R, Massollo M, Nieri A, Piccardo A, Vendramin L, Muratore F, Lavelli V, Albano D, Burroni L, Cuocolo A, Evangelista L, Lazzeri E, Quartuccio N, Rossi B, Rubini G, Sollini M, Versari A, Signore A. Casali M, et al. Among authors: giordano a. Clin Transl Imaging. 2021;9(4):299-339. doi: 10.1007/s40336-021-00445-w. Epub 2021 Jul 10. Clin Transl Imaging. 2021. PMID: 34277510 Free PMC article. Review.
p53 signaling in cancer progression and therapy.
Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Pozzoli G, Morrione A, Giordano A, Cenciarelli C. Marei HE, et al. Among authors: giordano a. Cancer Cell Int. 2021 Dec 24;21(1):703. doi: 10.1186/s12935-021-02396-8. Cancer Cell Int. 2021. PMID: 34952583 Free PMC article. Review.
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study.
Roberti R, Di Gennaro G, Anzellotti F, Arnaldi D, Belcastro V, Beretta S, Boero G, Bonanni P, Canafoglia L, D'Aniello A, Dainese F, De Caro C, Di Gennaro G, Di Giacomo R, DiFrancesco JC, Dono F, Falcicchio G, Ferlazzo E, Foschi N, Franciotta S, Gambardella A, Giordano A, Iannone LF, Labate A, La Neve A, Lattanzi S, Leggio U, Liguori C, Maschio M, Nilo A, Operto FF, Pascarella A, Pauletto G, Renna R, Strigaro G; COMPARE Study Group; Russo E. Roberti R, et al. Among authors: giordano a. Epilepsia. 2024 Feb;65(2):456-472. doi: 10.1111/epi.17843. Epub 2023 Dec 16. Epilepsia. 2024. PMID: 38052481
Exercise-Based Knee and Anterior Cruciate Ligament Injury Prevention.
Arundale AJH, Bizzini M, Dix C, Giordano A, Kelly R, Logerstedt DS, Mandelbaum B, Scalzitti DA, Silvers-Granelli H, Snyder-Mackler L. Arundale AJH, et al. Among authors: giordano a. J Orthop Sports Phys Ther. 2023 Jan;53(1):CPG1-CPG34. doi: 10.2519/jospt.2023.0301. J Orthop Sports Phys Ther. 2023. PMID: 36587265
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease.
Biagioli M, Marchianò S, Di Giorgio C, Bordoni M, Urbani G, Bellini R, Massa C, Sami Ullah Khan R, Roselli R, Chiara Monti M, Morretta E, Giordano A, Vellecco V, Bucci M, Jilani Iqbal A, Saviano A, Ab Mansour A, Ricci P, Distrutti E, Zampella A, Cieri E, Cirino G, Fiorucci S. Biagioli M, et al. Among authors: giordano a. Biochem Pharmacol. 2023 Dec;218:115900. doi: 10.1016/j.bcp.2023.115900. Epub 2023 Nov 3. Biochem Pharmacol. 2023. PMID: 37926268 Free article.
CSF-1R in Cancer: More than a Myeloid Cell Receptor.
Cersosimo F, Lonardi S, Ulivieri C, Martini P, Morrione A, Vermi W, Giordano A, Giurisato E. Cersosimo F, et al. Among authors: giordano a. Cancers (Basel). 2024 Jan 9;16(2):282. doi: 10.3390/cancers16020282. Cancers (Basel). 2024. PMID: 38254773 Free PMC article. Review.
A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis.
Pahlevan Kakhki M, Giordano A, Starvaggi Cucuzza C, Venkata S Badam T, Samudyata S, Lemée MV, Stridh P, Gkogka A, Shchetynsky K, Harroud A, Gyllenberg A, Liu Y, Boddul S, James T, Sorosina M, Filippi M, Esposito F, Wermeling F, Gustafsson M, Casaccia P, Hillert J, Olsson T, Kockum I, Sellgren CM, Golzio C, Kular L, Jagodic M. Pahlevan Kakhki M, et al. Among authors: giordano a. Nat Commun. 2024 Jul 30;15(1):6419. doi: 10.1038/s41467-024-50794-z. Nat Commun. 2024. PMID: 39079955 Free PMC article.
2,835 results